News

The Healthy @Reader's Digest6d
A Highly Popular Weight Loss Drug Has Been Recalled in 3 States
Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.
The American Journal of Managed Care4d
Novo Nordisk Expands GLP-1 Access Through Telehealth Providers
Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...
Managed Healthcare Executive4d
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Will Indians get blockbuster weight-loss drugs at cost of cheaper insulin?
Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...
Hims & Hers inks deal with Novo Nordisk to offer discounted ‘weight loss drug Wegovy’
Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...
Managed Healthcare Executive6d
Novo Nordisk Offers Wegovy Through Telehealth Providers, Including Hims & Hers
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...
Longview News-Journal6d
Novo Nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations
PLAINSBORO, N.J., April 29, 2025 /PRNewswire/ -- Today, Novo Nordisk announced it is expanding patient access to Wegovy ® (semaglutide) injection ... loss in its premium pen delivery device ...